KR20220034130A - 인플루엔자 바이러스 감염증을 치료하기 위한 의약 조성물 - Google Patents

인플루엔자 바이러스 감염증을 치료하기 위한 의약 조성물 Download PDF

Info

Publication number
KR20220034130A
KR20220034130A KR1020227002493A KR20227002493A KR20220034130A KR 20220034130 A KR20220034130 A KR 20220034130A KR 1020227002493 A KR1020227002493 A KR 1020227002493A KR 20227002493 A KR20227002493 A KR 20227002493A KR 20220034130 A KR20220034130 A KR 20220034130A
Authority
KR
South Korea
Prior art keywords
influenza virus
virus infection
imaging device
image
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227002493A
Other languages
English (en)
Korean (ko)
Inventor
쇼 오키야마
Original Assignee
아이리스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아이리스 가부시키가이샤 filed Critical 아이리스 가부시키가이샤
Publication of KR20220034130A publication Critical patent/KR20220034130A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/24—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the mouth, i.e. stomatoscopes, e.g. with tongue depressors; Instruments for opening or keeping open the mouth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00147—Holding or positioning arrangements
    • A61B1/00148—Holding or positioning arrangements using anchoring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/05—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances characterised by the image sensor, e.g. camera, being in the distal end portion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0088—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for oral or dental tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • A61B5/201—Assessing renal or kidney functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6814—Head
    • A61B5/682—Mouth, e.g., oral cavity; tongue; Lips; Teeth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/20—Heterogeneous data integration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Theoretical Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Quality & Reliability (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
KR1020227002493A 2019-07-03 2020-06-30 인플루엔자 바이러스 감염증을 치료하기 위한 의약 조성물 Ceased KR20220034130A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2019-124750 2019-07-03
JP2019124750 2019-07-03
PCT/JP2020/025652 WO2021002355A1 (ja) 2019-07-03 2020-06-30 インフルエンザウイルス感染症を治療するための医薬組成物

Publications (1)

Publication Number Publication Date
KR20220034130A true KR20220034130A (ko) 2022-03-17

Family

ID=74101322

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227002493A Ceased KR20220034130A (ko) 2019-07-03 2020-06-30 인플루엔자 바이러스 감염증을 치료하기 위한 의약 조성물

Country Status (9)

Country Link
US (2) US12245754B2 (https=)
EP (2) EP3995149A4 (https=)
JP (2) JPWO2021002355A1 (https=)
KR (1) KR20220034130A (https=)
CN (2) CN114340637A (https=)
BR (1) BR112021026839A2 (https=)
CA (1) CA3145200A1 (https=)
MX (1) MX2021016040A (https=)
WO (1) WO2021002355A1 (https=)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01148233A (ja) * 1987-12-07 1989-06-09 Olympus Optical Co Ltd マウスピース
JP3510343B2 (ja) * 1994-08-23 2004-03-29 オリンパス株式会社 電子内視鏡
US6257238B1 (en) * 2000-05-25 2001-07-10 Nizam M. Meah Bite block for upper gastrointestinal endoscopy with tongue depressor
FR2824723B1 (fr) * 2001-05-15 2003-08-15 Univ Joseph Fourier Embout destine a un dispositif d'evaluation de la sensibilite du pharynx, dispositif le comportant et procede d'utilisation
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
WO2005104926A1 (ja) * 2004-04-30 2005-11-10 J. Morita Manufacturing Corporation 生体観察機器、口腔内撮影装置及び医療用診療器具
WO2009023356A2 (en) * 2007-05-25 2009-02-19 Omega-Biopharma (H.K.) Limited Materials and methods for treating influenza infections
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
JP5145587B2 (ja) * 2007-12-27 2013-02-20 晃一 角田 口腔挿入具および口腔咽頭鏡装置
CN101787008A (zh) * 2009-01-23 2010-07-28 中国科学院上海药物研究所 N-乙酰神经氨酸类化合物、其药物组合物及其制备方法和用途
US10022449B2 (en) * 2009-12-22 2018-07-17 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
EP2868096B1 (en) * 2012-06-27 2020-08-05 Zipline Health, Inc. Devices, methods and systems for acquiring medical diagnostic information and provision of telehealth services
US9555094B2 (en) 2012-07-23 2017-01-31 The Institute Of Biological Resources Isolated nucleic acid for the production of a vaccine against virus
HK1209646A1 (en) 2012-12-28 2016-04-08 日本国立感染症研究所 Nasal influenza vaccine composition
MX387277B (es) 2013-03-14 2025-03-12 Contrafect Corp Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada.
US10632010B2 (en) * 2014-04-01 2020-04-28 Oventus Medical Limited Breathing assist device
EP3294106B1 (en) * 2015-05-12 2020-08-26 Zipline Health, Inc. Devices for acquiring medical diagnostic information and provision of telehealth services
CA2986363C (en) * 2015-05-19 2021-10-26 Tyto Care Ltd. Systems and methods for throat imaging
JP6837258B2 (ja) * 2016-11-18 2021-03-03 国立大学法人鳥取大学 喉頭鏡及び喉頭鏡用ブレード
JP6844088B2 (ja) * 2017-01-25 2021-03-17 株式会社メドレー 医療情報提供方法、医療情報提供装置、及びプログラム
US11104689B2 (en) * 2017-09-18 2021-08-31 Sunshine Lake Pharma Co., Ltd. Influenza virus replication inhibitor and use thereof
JP7267608B2 (ja) 2017-12-28 2023-05-02 アイリス株式会社 口内撮影装置、医療装置及びプログラム
CN109504721B (zh) * 2018-12-26 2021-07-09 杭州科巢生物科技有限公司 一种抗流感药物的合成方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
미야모토·와타나베 저 「인두의 진찰 소견(인플루엔자 여포)의 의미와 가치의 고찰」니치다이의지(日大醫誌) 72(1):11-18(2013)

Also Published As

Publication number Publication date
US20250176815A1 (en) 2025-06-05
EP4599758A2 (en) 2025-08-13
JPWO2021002355A1 (https=) 2021-01-07
EP3995149A4 (en) 2023-07-19
CN114340637A (zh) 2022-04-12
CN119679357A (zh) 2025-03-25
CA3145200A1 (en) 2021-01-07
US12245754B2 (en) 2025-03-11
EP3995149A1 (en) 2022-05-11
BR112021026839A2 (pt) 2022-02-22
EP4599758A3 (en) 2025-11-05
JP2025084816A (ja) 2025-06-03
US20220361741A1 (en) 2022-11-17
WO2021002355A1 (ja) 2021-01-07
MX2021016040A (es) 2022-03-11

Similar Documents

Publication Publication Date Title
US20230047709A1 (en) Intraoral Imaging Apparatus, Medical Apparatus, And Program
Singh et al. Foot-and-mouth disease virus: immunobiology, advances in vaccines and vaccination strategies addressing vaccine failures—an Indian perspective
TW201616441A (zh) 用於測定一藥學製劑之投藥方案的遵從性及有效性之系統及方法
WO2019131328A1 (ja) 口内撮影補助具、及びその口内撮影補助具を含む医療装置
KR20220034130A (ko) 인플루엔자 바이러스 감염증을 치료하기 위한 의약 조성물
JP2011110152A (ja) 美顔用マスク及びその製造方法
Salzmann et al. High-Precision Optical Coherence Tomography Navigated Laser Retinopexy for Retinal Breaks
Jones et al. Primary immunization of human papillomavirus vaccine in the pediatric population: what is the verdict now?
Žegarac Universal Influenza Vaccine: A Game Changer in Prevention
Žegarac Overcoming Challenges to Create a Universal Influenza Vaccine
Govindaswamy et al. EVALUATION OF ANTI-HBs RESPONSE IN HEPATITIS B VACCINATED HEALTH CARE WORKERS IN A TERTIARY CARE HOSPITAL OF RURAL KANCHEEPURAM DISTRICT, TAMIL NADU, INDIA
Remcho et al. Improved Methodology for Liquid Delivery to the Mouse Lung: Intubation using a Consumer Otoscope
Osti Hepatitis B virus: evaluation of infection risk and serological response to vaccine in hospital cleaners of the Botucatu School of Medicine
Prasad COVID-19 mRNA Vaccine: A Milestone in Science and a Game Changer in Medicine
Umeed Advising travellers on vaccine-preventable diseases
Savoy ACIP releases 2017 adult immunization recommendations
Fryhofer Adult Immunization 2012: Politics, Process, and Progress
CN205126180U (zh) 具有人体外方位标示功能的喉部器械
Namwena Experimental Ebola vaccination underway in the DRC
Ali Measles in Medical Students
Bermejo-Martin et al. Prepandemic influenza vaccines
Robaina et al. Correlationship of citopathology and histopathology on oral mucosa lesions after fine needle aspiration
Khanna et al. Vaccines for pandemic influenza A H1N1 (2009): where do we stand?
Dormitzer et al. Atomic models via electron cryomicroscopy
Dutta Customizing Stroke Rehabilitation Using a'Rehabilitation Problem-Solving Form'for a Home-Based Therapy Model in India

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601